Preferred Name: Dan Silverman
Daniel H. Silverman, M.D., Ph.D., is Head of the Neuronuclear Imaging Section of the Ahmanson Translational Imaging Division at UCLA Medical Center, on the Executive Committee of the UCLA Alzheimer's Disease Research Center, and Professor in the Department of Molecular and Medical Pharmacology, University of California, Los Angeles.
He obtained his Ph.D. in Biological Chemistry at Harvard University, and postdoctoral research training in Biochemistry and Molecular Pharmacology at Harvard Medical School. He obtained his M.D. from The Ohio State University College of Medicine, subsequently completed post-M.D. training at UCLA, and then obtained certification from both the American Board of Internal Medicine and the American Board of Nuclear Medicine.